Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening | Zendy

Denise R Aberle | Zendy; Amanda M Adams | Zendy; Christine D Berg | Zendy; William C Black | Zendy; Jonathan D Clapp | Zendy; Richard M Fagerstrom | Zendy; Ilana F Gareen | Zendy; Constantine Gatsonis | Zendy; Pamela M Marcus | Zendy; JoRean D Sicks | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Author(s) -

Denise R Aberle,

Amanda M Adams,

Christine D Berg,

William C Black,

Jonathan D Clapp,

Richard M Fagerstrom,

Ilana F Gareen,

Constantine Gatsonis,

Pamela M Marcus,

JoRean D Sicks

Publication year - 2011

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1102873

Subject(s) - national lung screening trial , lung cancer screening , lung cancer , medicine , computed tomographic , computed tomography , cancer , radiology , lung , nuclear medicine , oncology

The aggressive and heterogeneous nature of lung cancer has thwarted efforts to reduce mortality from this cancer through the use of screening. The advent of low-dose helical computed tomography (CT) altered the landscape of lung-cancer screening, with studies indicating that low-dose CT detects many tumors at early stages. The National Lung Screening Trial (NLST) was conducted to determine whether screening with low-dose CT could reduce mortality from lung cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research